000 | 01960 a2200529 4500 | ||
---|---|---|---|
005 | 20250517060043.0 | ||
264 | 0 | _c20160920 | |
008 | 201609s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.6092 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYeh, Wei-Lan | |
245 | 0 | 0 |
_aMigration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins. _h[electronic resource] |
260 |
_bOncotarget _cNov 2015 |
||
300 |
_a37770-81 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xgenetics |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCell Movement _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCurcumin _xpharmacology |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aFluorescent Antibody Technique |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 |
_aGlioma _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoenzyme Techniques |
650 | 0 | 4 |
_aMicroRNAs _xgenetics |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aLin, Hsiao-Yun | |
700 | 1 | _aHuang, Chiung-Yin | |
700 | 1 | _aHuang, Bor-Ren | |
700 | 1 | _aLin, Chingju | |
700 | 1 | _aLu, Dah-Yuu | |
700 | 1 | _aWei, Kuo-Chen | |
773 | 0 |
_tOncotarget _gvol. 6 _gno. 35 _gp. 37770-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.6092 _zAvailable from publisher's website |
999 |
_c25360297 _d25360297 |